Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells

被引：10
|
作者：
Banoth, Balaji [1 ]
Cassel, Suzanne L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; Bruton tyrosine kinase; ibrutinib;
D O I：
10.1016/j.jaci.2017.03.041
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：985 / 987
页数：3
相关论文
共 50 条
  • [1] Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny
    Minotti, Giorgio
    Camilli, Massimiliano
    Salvatorelli, Emanuela
    Menna, Pierantonio
    BRITISH JOURNAL OF PHARMACOLOGY, 2025, 182 (07) : 1446 - 1451
  • [2] Role of Bruton's tyrosine kinase in B cells and malignancies
    Singh, Simar Pal
    Dammeijer, Floris
    Hendriks, Rudi W.
    MOLECULAR CANCER, 2018, 17
  • [3] Role of Bruton’s tyrosine kinase in B cells and malignancies
    Simar Pal Singh
    Floris Dammeijer
    Rudi W. Hendriks
    Molecular Cancer, 17
  • [4] Functions of Bruton's tyrosine kinase in mast and B cells
    Kawakami, Y
    Kitaura, J
    Hata, D
    Yao, LB
    Kawakami, T
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) : 286 - 290
  • [5] Bruton Tyrosine Kinase Inhibition in Dermatology and Allergology
    Wedi, B.
    HAUTARZT, 2018, 69 (06): : 519 - 522
  • [6] Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders
    Castillo, Jorge J.
    Treon, Steven P.
    Davids, Matthew S.
    CANCER JOURNAL, 2016, 22 (01): : 34 - 39
  • [7] Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
    Simar Pal Singh
    Floris Dammeijer
    Rudi W. Hendriks
    Molecular Cancer, 18
  • [8] Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
    Wang, Haoran
    Guo, Hao
    Yang, Jingyi
    Liu, Yanyan
    Liu, Xingchen
    Zhang, Qing
    Zhou, Keshu
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [9] Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect
    Haoran Wang
    Hao Guo
    Jingyi Yang
    Yanyan Liu
    Xingchen Liu
    Qing Zhang
    Keshu Zhou
    Experimental Hematology & Oncology, 11
  • [10] Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia
    Maddocks, Kami
    Jones, Jeffrey A.
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 251 - 259
12345